Medicare Enrolled

Dr. Ranya Habash, M.D.

Ophthalmology · Boca Raton, FL
Consulting-driven
9325 GLADES RD, Boca Raton, FL 33434
5614881001
In practice since 2005 (20 years)
NPI: 1053310391 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Habash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Habash? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Habash

Dr. Ranya Habash is an ophthalmology in Boca Raton, FL, with 20 years in practice.

Between the years covered by Open Payments, Dr. Habash received a total of $86,568 from 25 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Habash is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $86,568 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$86,568
Total received (2018-2024)
Avg $12,367/year across 7 years
Top 5% in FL for ophthalmology
25
Companies
165
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$78,585 (90.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,983 (9.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$36,144
2023
$24,871
2022
$6,629
2021
$15,199
2020
$791
2019
$1,303
2018
$1,632

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$30,853
Carl Zeiss Meditec, Inc.
$17,794
Allergan, Inc.
$12,799
Amgen Inc.
$9,225
Alcon Vision LLC
$6,240
Dompe US, Inc.
$3,011
Johnson & Johnson Surgical Vision, Inc.
$1,666
ABBVIE INC.
$1,242
Boehringer Ingelheim International GmbH
$635
Alcon Laboratories Inc
$615
Sun Pharmaceutical Industries Inc.
$364
Bausch & Lomb, a division of Bausch Health US, LLC
$306
Kala Pharmaceuticals, Inc.
$245
Omeros Corporation
$244
Oyster Point Pharma, Inc.
$241
Glaukos Corporation
$149
SUN PHARMACEUTICAL INDUSTRIES INC.
$140
Carl Zeiss Meditec USA, Inc.
$131
Horizon Pharma plc
$122
Shire North American Group Inc
$121
Acclarent, Inc
$113
Carl Zeiss Meditec Cataract Technology Inc.
$110
TOPCON MEDICAL SYSTEMS, INC.
$90
Alcon Research LLC
$69
Boston Scientific Corporation
$44
Top 3 companies account for 71.0% of total payments
Associated products mentioned in payments ›
ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM · ACTIVEFOCUS · ARGOS · ARTEVO 800 · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · BromSite (bromfenac ophthalmic solution) 0.075% · CALLISTO eye · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · CIRRUS 6000 with AngioPlex · CIRRUS HD-OCT · Catalys Laser System · Centurion · Cequa · Clareon · FORUM · IC-8 Apthera IOL · INVELTYS · IOLMaster 500 · IOLMaster 700 · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · LOTEMAX GEL · LUMIGAN · MIEBO · NGENUITY · OMIDRIA · ORA · OXERVATE · PanOptix · RESTASIS MULTIDOSE · SMART Suite · STELLARIS · TECNIS IOL · TEPEZZA · TEPRO · TYRVAYA · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Simplicity · Tecnis Symfony IOL · VERACITY SURGICAL · VUITY · VisuMax · Wavelight Refractive Suite · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · enVista Aspire IOL · enVista MX60 IOL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for ophthalmology in FL.

Looking for a ophthalmology in Boca Raton?
Compare ophthalmologys in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
215
Per 100K population
14.3
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
4.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Habash is a ophthalmology, and high industry engagement (consulting-driven, top 5%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Habash receive payments from pharmaceutical companies?
Yes. Dr. Habash received a total of $86,568 from 25 companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Habash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →